Zacks: Analysts Expect MAXIMUS, Inc. (NYSE:MMS) Will Announce Quarterly Sales of $760.56 Million

Equities research analysts forecast that MAXIMUS, Inc. (NYSE:MMS) will post $760.56 million in sales for the current fiscal quarter, Zacks reports. Four analysts have issued estimates for MAXIMUS’s earnings, with estimates ranging from $752.31 million to $772.65 million. MAXIMUS reported sales of $558.45 million during the same quarter last year, which indicates a positive year-over-year growth rate of 36.2%. The firm is expected to report its next quarterly earnings report on Tuesday, November 19th.

According to Zacks, analysts expect that MAXIMUS will report full-year sales of $2.90 billion for the current financial year, with estimates ranging from $2.88 billion to $2.92 billion. For the next financial year, analysts expect that the company will report sales of $3.18 billion, with estimates ranging from $3.13 billion to $3.22 billion. Zacks’ sales calculations are a mean average based on a survey of research firms that follow MAXIMUS.

MAXIMUS (NYSE:MMS) last announced its quarterly earnings data on Thursday, August 8th. The health services provider reported $0.97 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.93 by $0.04. The business had revenue of $730.70 million during the quarter, compared to analyst estimates of $754.81 million. MAXIMUS had a return on equity of 20.72% and a net margin of 8.44%. The company’s revenue was up 22.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.91 earnings per share.

Several brokerages have recently commented on MMS. ValuEngine downgraded MAXIMUS from a “hold” rating to a “sell” rating in a report on Monday. Canaccord Genuity upped their target price on MAXIMUS from $72.00 to $77.00 and gave the company a “hold” rating in a report on Tuesday, August 13th. Finally, Wells Fargo & Co reaffirmed a “market perform” rating and set a $83.00 target price on shares of MAXIMUS in a report on Friday, August 9th.

Shares of NYSE MMS traded up $0.76 during mid-day trading on Friday, hitting $74.49. 20,365 shares of the company traded hands, compared to its average volume of 364,097. MAXIMUS has a 1 year low of $60.00 and a 1 year high of $82.02. The stock has a market capitalization of $4.73 billion, a price-to-earnings ratio of 22.11, a PEG ratio of 1.81 and a beta of 0.87. The business has a 50 day moving average of $77.49 and a two-hundred day moving average of $74.14.

The business also recently announced a quarterly dividend, which will be paid on Friday, November 29th. Stockholders of record on Friday, November 15th will be issued a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 1.50%. This is an increase from MAXIMUS’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Thursday, November 14th. MAXIMUS’s dividend payout ratio is currently 29.41%.

In other news, Vice Chairman Richard A. Montoni sold 11,000 shares of the company’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $80.40, for a total transaction of $884,400.00. Following the completion of the sale, the insider now directly owns 337,874 shares of the company’s stock, valued at $27,165,069.60. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Vice Chairman Richard A. Montoni sold 12,000 shares of the company’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $78.04, for a total value of $936,480.00. Following the sale, the insider now directly owns 337,874 shares of the company’s stock, valued at $26,367,686.96. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 55,496 shares of company stock valued at $4,398,575. 2.20% of the stock is currently owned by company insiders.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Advisory Services Network LLC raised its position in MAXIMUS by 499.0% during the second quarter. Advisory Services Network LLC now owns 593 shares of the health services provider’s stock valued at $43,000 after buying an additional 494 shares during the period. Quantamental Technologies LLC acquired a new position in MAXIMUS during the second quarter valued at $71,000. Signaturefd LLC raised its position in MAXIMUS by 19.6% during the second quarter. Signaturefd LLC now owns 1,145 shares of the health services provider’s stock valued at $83,000 after buying an additional 188 shares during the period. Tower Research Capital LLC TRC raised its position in MAXIMUS by 70.8% during the second quarter. Tower Research Capital LLC TRC now owns 1,500 shares of the health services provider’s stock valued at $109,000 after buying an additional 622 shares during the period. Finally, Marshall Wace North America L.P. acquired a new position in MAXIMUS during the first quarter valued at $119,000. 94.78% of the stock is owned by institutional investors and hedge funds.

MAXIMUS Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

Recommended Story: Beta

Get a free copy of the Zacks research report on MAXIMUS (MMS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.